T
HE homotransplantation of nerves is not affected by one major problem encountered in transplantation of kidneys and other organs. These organs require survival of the actual cells in order to achieve a successful transplant, whereas the nerve homograft acts only as a tube for regeneration of the host nerve axons through it. It seems plausible, therefore, that immunosuppressive drugs could be used in nerve grafting until regeneration takes place and then discontinued. At the present time kidney homografts have succeeded for long periods of time during which immunosuppressive drugs have have been used without adverse effects on the host.5-7
The drug selected for study was 6-(1-methyl-4-nitro-5-imidazolyl) thiopurine, commonly called Imuran. During research on thiopurines in mice, the drug suppressed the formation of hemagglutinins to sheep cells and also inhibited the immune reaction to renal transplants in animalsY
Other investigators have confirmed this suppression of the immune response in a variety of animals. In investigations of organ homografts, it was apparent that Imuran would increase survival; in skin homografts, however, Inmran was much less effective.
The dosage advised for humans, according to Rundles, s varies from 1.5 to 3 mg/kg/day. Patients were able to take 1.5-3 mg kg/day (100-150 mg/day) for long periods without signs of toxicity. Higher doses, which are at times necessary, may produce anorexia, nausea, and malaise.
Murray 6,7 set up the following protocol for his patients receiving renal transplants:
Imuran:
3-4 mg/kg/day orally. Azaserine: 0.5 to 1.0 mg/kg intravenously for 31 days.
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Prednisone:
60-80 mg orally for 6-7 days, then 15 mg thereafter if rejection does not reverse with Actinomycin C. Actinomycin C : 6 mg/kg intravenously weekly starting at Day 31.
Toxicity has not been a major problem in organ transplantation, and, since the lower doses could be used in nerve transplantation, toxicity would not be a hindrance.
Experiment 1
Method. An experiment was set up to study the effect of an immunosuppressive drug on homotransplantation of peripheral nerves and to compare it with irradiation of the graft and with a combination of both methods.3,4 Thirty-two Sprague-Dawley rats weighing 350-300 gm were used in the study.
Inluran was selected as the immunosuppressive drug because of its wide use in renal homotransplantation. A dose of Imuran was used that would have minimal toxic effect, since the drug could only have value in nerve transplantation if toxicity was of no concern. The oral dose was therefore established as 300 mg/kg of diet, a dose found to have minimal toxicity in previous studies.
The rats were administered the drug orally in their regular laboratory feed for 5 days. A 1 cm segment of homogenous sciatic nerve was then implanted subcutaneously in the anterior thigh of half of the rats. In the other half an irradiated homograft was implanted subcutaneously. The same dose of Imuran was continued during the study, and no evidence of toxicity from the drug was observed.
Results. The animals were killed at weekly intervals and microscopic examination performed on the nerve implants using hematoxylin and eosin stain. At 3 weeks there was no evidence of destruction of the irradiated graft (Fig. 1 A) . The nonirradiated graft was also intact with little evidence of inflamma-
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Fro. 8 A. A nonirradiated implant was used as a control in a rat that was not treated with Imuran. Marked destruction is taking place due to rejection at 5 weeks.
H. & E., )<44.

FIG. 3 B. Marked cellular invasion is noted under higher magnification. H. & E., )<168.
t o r y response (Fig. 1 B) . E x a m i n a t i o n of the n o n -i r r a d i a t e d i m p l a n t at 5 weeks revealed v e r y little i n f l a m m a t o r y response a l t h o u g h some of the axis cylinders were d i s r u p t e d (Fig. ~ A) . T h e n o n i r r a d i a t e d i m p l a n t at 5 weeks revealed very little evidence of rejection (Fig. i~ B) . T h e results were graded on the evidence of i n f l a m m a t o r y response b o t h grossly a n d microscopically (Table 1) . T h e response was graded from 0 (no response) to 5 (severe d e s t r u c t i o n a n d r e p l a c e m e n t b y sear tissue). I t a p p e a r e d from these results t h a t I m u r a n a t n o n t o x i c dosages has a significant imm u n o s u p p r e s s i v e action on t h e rejection of n o n i r r a d i a t e d homografts (Fig. 3) . E x p e r i m e n t 2
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